Last reviewed · How we verify

NCT07421817: PONV-DEX-GYN

Dexamethasone for Prevention of Postoperative Vomiting After Laparoscopic Gynecologic Surgery

Completed NA Last updated 20 February 2026
What this trial tests

NA trial testing Dexamethasone in Postoperative Nausea and Vomiting (PONV) in 120 participants. Completed in 31 March 2018.

Timeline
1 October 2017
Primary endpoint
31 March 2018
31 March 2018

Quick facts

Lead sponsorRawalpindi Medical College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment120
Start date1 October 2017
Primary completion31 March 2018
Estimated completion31 March 2018
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Rawalpindi Medical College

Who can join

Adults 15 to 65, female only, with Postoperative Nausea and Vomiting (PONV). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative nausea and vomiting (PONV) are common and distressing complications following laparoscopic gynecologic surgery. This randomized controlled trial evaluated whether a single preoperative intravenous dose of dexamethasone reduces postoperative vomiting compared with placebo and explored patient-related risk factors associated with PONV. Women undergoing elective laparoscopic gynecologic surgery were randomly assigned to receive dexamethasone (5 mg IV) or placebo at induction of anesthesia. The primary outcome was the incidence of postoperative vomiting within 24 hours, with secondary outcomes including nausea severity, rescue antiemetic use, and postoperative recovery parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexamethasone

Trials testing the same drug.

Other recruiting trials for Postoperative Nausea and Vomiting (PONV)

Currently open trials in the same condition.

Other Rawalpindi Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07421817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing